Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.41M Sell
26,951
-61,071
-69% -$3.23M 0.02% 377
2026
Q1
$4.86M Buy
88,022
+877
+1% +$47.5K 0.09% 130
2025
Q4
$4.27M Buy
87,145
+57,689
+196% +$2.69M 0.08% 131
2025
Q3
$1.27M Buy
29,456
+19,458
+195% +$760K 0.03% 354
2025
Q2
$384K Buy
9,998
+354
+4% +$13.5K 0.01% 674
2025
Q1
$374K Buy
+9,644
New +$353K 0.01% 660
2024
Q4
Sell
-7,526
Closed -$308K 953
2024
Q3
$308K Buy
+7,526
New +$308K 0.01% 720
2024
Q2
Sell
-20,478
Closed -$878K 902
2024
Q1
$878K Buy
+20,478
New +$844K 0.03% 347
2022
Q1
Sell
-3,662
Closed -$202K 835
2021
Q4
$202K Buy
+3,662
New +$190K 0.01% 775

Other funds holding GSK

Diversified Trust's GSK Position: Q2 2026 in Review

Diversified Trust reduced its GSK (GSK) stake by 69% in Q2 2026, selling an estimated $3.23M and leaving 26,951 shares worth $1.41M. The position accounts for 0.02% of the portfolio, ranked #377.

Diversified Trust first reported a position in GSK in Q4 2021 and has held it in 9 quarters since. The position peaked at $4.86M in Q1 2026. 248 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Diversified Trust held 26,951 shares of GSK worth $1.41M as of Q2 2026.
  • Diversified Trust sold 61,071 GSK shares in Q2 2026, an estimated $3.23M.
  • GSK made up 0.02% of Diversified Trust's portfolio in Q2 2026, its #377 holding.
  • Diversified Trust first reported a position in GSK in Q4 2021 and has held it in 9 quarters since.
  • Diversified Trust's GSK position peaked at $4.86M in Q1 2026.
  • 248 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.